Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Deloitte
Citi
Mallinckrodt
Johnson and Johnson
Cantor Fitzgerald
Federal Trade Commission
AstraZeneca

Generated: June 25, 2018

DrugPatentWatch Database Preview

COACTIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Coactin patents expire, and when can generic versions of Coactin launch?

Coactin is a drug marketed by Roche and is included in one NDA.

The generic ingredient in COACTIN is amdinocillin. There are three drug master file entries for this compound. Additional details are available on the amdinocillin profile page.
Summary for COACTIN
Drug patent expirations by year for COACTIN
Medical Subject Heading (MeSH) Categories for COACTIN
Synonyms for COACTIN
(2S-(2alpha,5alpha,6beta))-6-(((Hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-(((Hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-[(azepan-1-ylmethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(1E)-azepan-1-ylmethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
32887-01-7
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (+)-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((hexahydro-1H-azepin-1-yl)methylene)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-
51556-89-9
6-((Hexahydro-1H-azepin-1-yl)methyleneamino)penicillanic acid
6beta-[(azepan-1-ylmethylidene)amino]-2,2-dimethylpenam-3alpha-carboxylic acid
70178-27-7
73937-07-2
79580-20-4
AB01209740-01
AC1L1VGC
ACT03258
AJ-45747
AK128398
AKOS022185296
Ambap32887-01-7
AMDINOCILLIN
Amdinocillin (USAN)
Amdinocillin [USAN:USP]
Amdinocillin [USAN]
Amdinocillin Mecillinam
BRD-K41051431-001-01-6
C15H23N3O3S
C21545
CAS-32887-01-7
CCG-100873
CHEMBL258646
CHEMBL530
Coactin (TN)
CPD000466361
CTK8F0546
D02888
D0M1VC
DB01163
DR001482
DSSTox_CID_2584
DSSTox_GSID_22584
DSSTox_RID_76643
DTXSID3022584
EINECS 251-277-1
FL 1060
FL-1060
FT-0630871
FT-0661552
HE335463
Hexacillin
hexapen
HMS2051E14
LS-149883
Mecilinamo
Mecilinamo [INN-Spanish]
Mecillinam
Mecillinam (INN)
Mecillinam [INN]
Mecillinam, VETRANAL(TM), analytical standard
Mecillinamum
Mecillinamum [INN-Latin]
MFCD00056869
MICILLINAM
MLS000759478
MLS001424041
NC00123
NCGC00164583-01
NCGC00164583-02
NCGC00188988-01
Penicillin HX
rel-(2R,6S)-6-{[(1E)-azepan-1-ylmethylene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Ro 10-9070
Ro 109070
Ro-10-9070
Ro-109070
SAM001246687
SCHEMBL34387
SCHEMBL34388
Selexidin
SMR000466361
ST24047524
Tox21_112209
Tox21_112209_1
TR-013801
UNII-V10579P3QZ
V10579P3QZ
ZINC12469558
ZINC3830206

US Patents and Regulatory Information for COACTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche COACTIN amdinocillin INJECTABLE;INJECTION 050565-003 Dec 21, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche COACTIN amdinocillin INJECTABLE;INJECTION 050565-001 Dec 21, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche COACTIN amdinocillin INJECTABLE;INJECTION 050565-002 Dec 21, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
McKinsey
UBS
Moodys
Chinese Patent Office
Fuji
Federal Trade Commission
AstraZeneca
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.